Results 151 to 160 of about 2,119,577 (353)

Evaluation of an Instrument for Screening Patients at Risk for Chronic Kidney Disease: Testing SCORED (Screening for Occult Renal Disease) in a Portuguese Population [PDF]

, 2012
Edgar Almeida, Carlota Lavinas, Catarina Teixeira, Mário Raimundo, Cristina Nogueira, Maria João Melo, Martina Ferreira, António Sampaio Soares, Inês Henriques, Cecília Teixeira, Sofia Almeida, António Gomes da Costa, Miguel Leal   +12 more
openalex   +1 more source

Reduction in Renal Relapse and Preservation of Long‐Term Kidney Function After Lupus Low Disease Activity in Patients With Lupus Nephritis

Arthritis Care &Research, EarlyView.
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE), but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung, Desmond Y. H. Yap, Ka Lai Lee, Philip H. Li, Iris Y. K. Tang, Chak Sing Lau, Shirley C. W. Chan   +6 more
wiley   +1 more source

Monocytes prevent apoptosis of iPSCs and promote differentiation of kidney organoids

Stem Cell Research & Therapy
Background Induced pluripotent stem cells (iPSCs)-derived kidney organoids are a promising model for studying disease mechanisms and renal development. Despite several protocols having been developed, further improvements are needed to overcome existing ...
Ekaterina Pecksen, Sergey Tkachuk, Cristoph Schröder, Marc Vives Enrich, Anindita Neog, Cory P. Johnson, Niko Lachmann, Hermann Haller, Yulia Kiyan   +8 more
doaj   +1 more source

Carotid Plaque, Carotid Intima-Media Thickness, and Coronary Calcification Equally Discriminate Prevalent Cardiovascular Disease in Kidney Disease [PDF]

, 2012
Gbemisola A. Adeseun, Dawei Xie, Xin Wang, Marshall M. Joffe, Emile R. Mohler, Raymond R. Townsend, Matthew J. Budoff, Sylvia E. Rosas   +7 more
openalex   +1 more source

A Scoping Review on Artificial Intelligence–Supported Interventions for Nonpharmacologic Management of Chronic Rheumatic Diseases

Arthritis Care &Research, EarlyView.
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah, Alexis Castellanos, Yen Chen, John Piette, Amy Bucher, Susan Murphy   +5 more
wiley   +1 more source

Comparations of efficacy and safety of rituximab, calcineurin inhibitors and cyclophosphamide in primary membranous nephropathy: a single-center retrospective analysis

BMC Nephrology
Background To compare the efficacy and safety of rituximab (RTX), calcineurin inhibitor (CNI) and cyclophosphamide (CTX) plus glucocorticoids in the treatment of primary membranous nephropathy (PMN).
Luying Lu, Shasha Cai, Huayan Zhu, Guangjun Liu, Yaomin Wang, Pingping Ren, Lan Lan, Xiaoqi Shen, Liangliang Chen, Ying Xu, Jun Cheng, Xiayu Li, Jianghua Chen, Fei Han   +13 more
doaj   +1 more source

Circulating methylarginine levels and the decline in renal function in patients with chronic kidney disease are modulated by DDAH1 polymorphisms [PDF]

, 2009
Ben Caplin, Dorothea Nitsch, Herpreet Gill, Richard Hoefield, Scott Blackwell, Douglas Mackenzie, Jackie A. Cooper, Rachel Middleton, Philippa J. Talmud, P S Veitch, Jill T. Norman, David C. Wheeler, James Leiper   +12 more
openalex   +1 more source

Mesoamerican Nephropathy and Kidney Disease Progression: A Case Series of Individuals With Kidney Biopsies From Nicaragua and El Salvador

, 2021
Julia Wijkström, Marvin González-Quiroz, Ricardo Leiva, Zulma Trujillo, Carl‐Gustaf Elinder, Annika Wernerson   +5 more
openalex   +1 more source

Hydroxychloroquine Associated With Lower Glomerular Filtration Rate Decline in Lupus Nephritis

Arthritis Care &Research, EarlyView.
Objective Hydroxychloroquine (HCQ) protects kidney function in lupus nephritis (LN) by preventing flares, yet some cohort studies show no significant benefit in kidney function with HCQ. Clarifying these conflicting findings by showing early and long‐term benefits of HCQ on kidney function preservation is critical.
Shivani Garg, Brad Rovin, Brad C. Astor, Tripti Singh, Fauzia Hollnagel, Megan Kuik, Lexie Kolton, Callie Saric, S. Sam Lim, Christie M. Bartels   +9 more
wiley   +1 more source

Efficacy of CD19-guided B-cell depletion with rituximab plus steroids in refractory focal segmental glomerulosclerosis

BMC Nephrology
Objective Refractory focal segmental glomerulosclerosis (FSGS) poses significant therapeutic challenges under conventional immunosuppressants. Although rituximab (RTX), an anti-CD20 monoclonal antibody, has demonstrated efficacy in nephrotic syndrome ...
Liangliang Chen, Xiaoli Lin, Xiaohan Huang, Yanhong Ma, Fanghao Cai, Huanhuan Zhu, Lan Lan, Pingping Ren, Jianghua Chen, Junni Wang, Fei Han   +10 more
doaj   +1 more source